The effect of Corynebacterium parvum on the proliferation of monocyte precursors in the bone marrow of mice
- PMID: 415919
The effect of Corynebacterium parvum on the proliferation of monocyte precursors in the bone marrow of mice
Abstract
The anti-tumour activity of C. parvum is thought to be mediated via the monocyte/macrophage system (Scott, 1974). These cells originate from rapidly dividing precursors in the bone marrow and it might be at this level that C. parvum exerts its action. To test this hypothesis bone marrow T0 Swiss mice has been cultured according to the method of Bradley and Metcalf (1966), which gives an index of the number of proliferating macrophage precursor cells at the time of sacrifice. Experiments were set up at various times following a single i.p. injection of 700 microgram of an anti-tumour strain of C. parvum (CN 6134-Wellcome Research Laboratories). Controls received 700 microgram of either C. diphtheriae CN 2000 or C. parvum CN 5888, a strain with no anti-tumour activity. Macrophage colony counts in those mice receiving "active" C. parvum were significantly higher than those in controls at intervals from 2 h to 3 weeks post-treatment. This time course parallels certain immunological properties of C. parvum and suggests a possible mode of action.
Similar articles
-
Effect of Corynebacterium parvum on colony-stimulating factor and granulocyte-macrophage colony formation.Cancer Res. 1977 May;37(5):1349-55. Cancer Res. 1977. PMID: 300651
-
Effect of Corynebacterium parvum on the proliferative rate of granulocyte-macrophage progenitor cells and the toxicity of chemotherapy.Cancer Res. 1978 Sep;38(9):2666-72. Cancer Res. 1978. PMID: 679169
-
The effect of bone marrow depletion on prostaglandin E-producing suppressor macrophages in mouse spleen.J Immunol. 1985 Dec;135(6):3897-904. J Immunol. 1985. PMID: 2933455
-
Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.J Immunol. 1987 Apr 1;138(7):2366-71. J Immunol. 1987. PMID: 3104463
-
Mitogenicity of Corynebacterium parvum for mouse lymphocytes.Clin Exp Immunol. 1975 Dec;22(3):514-21. Clin Exp Immunol. 1975. PMID: 817854 Free PMC article.
Cited by
-
Effect of intravenous corynebacterium parvum on peripheral-blood effector cells of cancer patients.Br J Cancer. 1980 May;41(5):782-9. doi: 10.1038/bjc.1980.142. Br J Cancer. 1980. PMID: 7426303 Free PMC article.
-
Immunochemotherapy of breast cancer with Propionibacterium granulosum.Cancer Immunol Immunother. 1983;15(1):23-6. doi: 10.1007/BF00199457. Cancer Immunol Immunother. 1983. PMID: 6553504 Free PMC article. Clinical Trial.
-
Small-cell lung cancer and immunochemotherapy with Propionibacterium granulosum KP 45.J Cancer Res Clin Oncol. 1985;109(1):72-7. doi: 10.1007/BF01884258. J Cancer Res Clin Oncol. 1985. PMID: 2982882 Free PMC article. Clinical Trial.